Combined loss of HLA I and HLA II expression is more common in the non‐GCB type of diffuse large B cell lymphoma

Combined loss of HLA I and HLA II expression is more common in the non‐GCB type of diffuse... Sir: As an immune escape mechanism, tumour cells may down‐regulate expression of human leucocyte antigens (HLA). Loss of HLA classes I and II has been described in various subtypes of diffuse large B cell lymphoma (DLBCL), including the not otherwise specified (NOS) subgroup. We analysed HLA classes I and II expression in DLBCL‐NOS to investigate whether there is an association between HLA expression, cell of origin (COO) and the recently reported FoxP1 expression in non‐GCB DLBCL.Seventy‐seven cases of DLBCL‐NOS with an almost exclusively nodal presentation were classified for COO by immunohistochemistry (IHC) according to the Hans algorithm as germinal centre B (GCB) cell‐type (n = 42) or non‐GCB‐type (n = 35) (Table ). Clinical data available from 67 cases indicated a histologically confirmed pre‐existent or concurrent indolent lymphoma in 16 patients, i.e. 13 follicular lymphoma, two marginal zone lymphoma and one chronic lymphocytic leukaemia. Expression of HLA and FoxP1 was assessed by IHC; methods are described in the Supporting Information.Features of DLBCL‐NOS casesCharacteristicNon‐GCB (35)GCB (42)P‐valueMale (%)23 (66)24 (57)Median age (years; range)66 (9–85)56 (14–77)Ann Arbor stageI/II (%)6 (17)18 (43)III/IV (%)26 (74)18 (43)Unknown (%)3 (9)6 (14)IPI0–1 (%)5 (14)13 (31)2–3 (%)19 (55)18 (43)4–5 (%)7 (20)1 (2)Unknown (%)4 (11)10 (24)Transformation (%)2 (6)14 (33)<0.01HLA http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Histopathology Wiley

Combined loss of HLA I and HLA II expression is more common in the non‐GCB type of diffuse large B cell lymphoma

Loading next page...
 
/lp/wiley/combined-loss-of-hla-i-and-hla-ii-expression-is-more-common-in-the-non-xRuKYRJBQt
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 John Wiley & Sons Ltd
ISSN
0309-0167
eISSN
1365-2559
D.O.I.
10.1111/his.13445
Publisher site
See Article on Publisher Site

Abstract

Sir: As an immune escape mechanism, tumour cells may down‐regulate expression of human leucocyte antigens (HLA). Loss of HLA classes I and II has been described in various subtypes of diffuse large B cell lymphoma (DLBCL), including the not otherwise specified (NOS) subgroup. We analysed HLA classes I and II expression in DLBCL‐NOS to investigate whether there is an association between HLA expression, cell of origin (COO) and the recently reported FoxP1 expression in non‐GCB DLBCL.Seventy‐seven cases of DLBCL‐NOS with an almost exclusively nodal presentation were classified for COO by immunohistochemistry (IHC) according to the Hans algorithm as germinal centre B (GCB) cell‐type (n = 42) or non‐GCB‐type (n = 35) (Table ). Clinical data available from 67 cases indicated a histologically confirmed pre‐existent or concurrent indolent lymphoma in 16 patients, i.e. 13 follicular lymphoma, two marginal zone lymphoma and one chronic lymphocytic leukaemia. Expression of HLA and FoxP1 was assessed by IHC; methods are described in the Supporting Information.Features of DLBCL‐NOS casesCharacteristicNon‐GCB (35)GCB (42)P‐valueMale (%)23 (66)24 (57)Median age (years; range)66 (9–85)56 (14–77)Ann Arbor stageI/II (%)6 (17)18 (43)III/IV (%)26 (74)18 (43)Unknown (%)3 (9)6 (14)IPI0–1 (%)5 (14)13 (31)2–3 (%)19 (55)18 (43)4–5 (%)7 (20)1 (2)Unknown (%)4 (11)10 (24)Transformation (%)2 (6)14 (33)<0.01HLA

Journal

HistopathologyWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial